logo
  • SELECT LICENSE :

  • US $4,299.00
  • US $8,599.00

Microsurgery Market, By Procedure (Free Flap Tissue Transfer, Transplantation, Replantation, Vascular Anastomoses), By Application (Neurosurgery, Ophthalmology, General Surgery, Oncology, Reconstructive and Plastic Surgery) opportunities and forecast 2020-2027

  • DLR2128
  • 19 September, 2020
  • Pharma & Healthcare
  • Pages: 120
  • Global
Market Overview

Microsurgery is one of well-known medical processes within surgical industry. Formerly, these methods were done to cure skin conditions; though, nowadays, the microsurgery has wide range of uses. Despite saturation in the developed countries, market for the microsurgery in life science and healthcare is expected to grow.

The increasing occurrence of the diseases such as melanoma, breast cancer, and non-melanoma skin cancer, prostate cancer, barrette’s esophagus, and others are major drivers boosting market growth. On the other hand, the high cost of surgery procedures and the complications associated with the surgery along with the limitations due to the patient’s anatomy are expected to hamper growth of the market.

Segment Overview

The market growth is accredited to continuous development of advanced technologies and strong demand for the surgical technology in the developing countries from APAC region would drive growth of microsurgery market. Furthermore, the rising incidence of diseases including prostate cancer, breast cancer, and non-melanoma skin cancer, melanoma, barrette’s esophagus, and others is further expected to drive market growth.

Further, according to World Health Organization (WHO), almost 2 to 3 million of non-melanoma skin cancers and around 132,000 of melanoma skin cancers cases take place each year worldwide. The growing demand for the microsurgery in the developing countries will result in more noteworthy market development that will benefit global microsurgery industry. Conversely, side-effects and complications related to surgery, high costs, and restriction due to patient’s anatomy are probable to hinder growth of the market.

Regional Overview

The North America is projected to dominate global microsurgery market over the forecast period. The growing prevalence of the diseases such as arthritis and cataract, along with rising demand for various aesthetic procedures within region are few of the main driving factors for market growth. The European market on the other hand for microsurgery is anticipated to be second-largest during forecast period. Growing prevalence of the diseases such as arthritis, medical complications associated to the neurosurgery has augmented healthcare demands for diagnosis and treatment of arthritis and cataract within the region is anticipated to boost growth of the market in the region.

Asia-Pacific is projected to be fastest-growing market due to rising geriatric population, and increasing incidence of dental diseases have increased the growth of market. Additionally, improving healthcare infrastructure has further increased the number of various research activities in region. Additionally, the market in Middle East and Africa is anticipated to witness stable growth due to inadequate access to the healthcare facilities.

Competitor overview

In February 2018, the Stryker Corporation declared that FDA delivered an expanded indication for Trevo Clot Retriever.
In November 2017, company, Alcon introduced a newly optimized UltraSert pre-loaded IOL i.e. intraocular lens delivery system.

Key Players
  1. S&T AG, Aesculap, Inc.
  2. Synovis Micro Companies Alliance, Inc.
  3. Stryker Corporation
  4. Ethicon Inc.
  5. Alcon (Novartis)
  6. Smith & Nephew
  7. Zimmer Biomet Holdings
  8. Medtronic PLC
  9. Carl Zeiss Meditec AG
  10. Peter Lazic GmbH
  11. Microsurgery Instruments, Inc.
  12. Tisurg medical instruments Co., Ltd
  13. Microline Surgical
  14. Halma PLC
  15. AROSurgical Instruments

Market Segmentation

By Procedure
  • Transplantation
  • Free Flap Tissue Transfer
  • Replantation
  • Vascular Anastomoses
By Application
  • General Surgery
  • Ophthalmology
  • Neurosurgery
  • Reconstructive & Plastic Surgery
  • Oncology
By Geography
  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • UAE
    • Rest of LAMEA


1 Report Prologue 17

    2 Market Introduction 19

    • 2.1 Scope of Study 20
    • 2.2 Research Objective 20
    • 2.3 List of Assumptions 21
    • 2.4 Market Structure 21

    3 Research Methodology 22

    • 3.1 Research Methodology - Microsurgery Market 23
    • 3.2 Data Mining 24
    • 3.3 Secondary Research 24
      • 3.3.1 Data points received from the secondary research 25
    • 3.4 Primary Research 25
      • 3.4.1 Data points received from surgeons & consulting physicians 26
      • 3.4.2 Data points received from the manufacturer 26
    • 3.5 FORECASTING TECHNIQUES 27
    • 3.6 Research Methodology for Market Size Estimation 28
    • 3.7 DATA TRIANGULATION 29
    • 3.8 Validation 29

    4 Market Dynamics 30

    • 4.1 Introduction 31
    • 4.2 Drivers 31
      • 4.2.1 Growing demand and cases of microsurgery 31
      • 4.2.2 Increase in the prevalence of certain conditions needing microsurgery 31
      • 4.2.3 Increasing acceptance of minimally invasive surgeries and growing per capita income would drive the growth of the market 32
    • 4.3 Restraints 32
      • 4.3.1 Complications and side-effects 32
      • 4.3.2 Cost of microsurgery 32
      • 4.3.3 Limitation due to patients’ anatomy 32
    • 4.4 Opportunities 33
      • 4.4.1 Technological advancement with the assistance of R&D 33
    • 4.5 Challenges 33
      • 4.5.1 Scarcity of trained professionals 33

    5 Market Factor Analysis 34

    • 5.1 Porter’s Five Force Analysis 35
      • 5.1.1 Threat from a New Entrant 35
      • 5.1.2 Bargaining Power of Buyer 36
      • 5.1.3 Bargaining Power of Supplier 36
      • 5.1.4 Threat from substitute 36
      • 5.1.5 Intensity of Competitive Rivalry 36
    • 5.2 Value Chain Analysis 37
      • 5.2.1 Raw Material 37
      • 5.2.2 Supplier 37
      • 5.2.3 Manufacturer 38
      • 5.2.4 Distributor 38
      • 5.2.5 Customer-Retailer 38
      • 5.2.6 Consumer 39
    • 5.3 Investment Opportunity Analysis 39
      • 5.3.1 Investment risks 39
      • 5.3.2 Market outlook 39
      • 5.3.3 Competitors 40
      • 5.3.4 Projections 40
    • 5.4 Pricing analysis 40

    6 Global Microsurgery Market, By Procedure 41

    • 6.1 Introduction 42
    • 6.2 Transplantation 43
    • 6.3 Replantation 44
    • 6.4 Free Flap Tissue Transfer 44
    • 6.5 Vascular Anastomoses 44

    7 Global Microsurgery Market, By Application 45

    • 7.1 Introduction 46
    • 7.2 General Surgery 47
    • 7.3 Neurosurgery 48
    • 7.4 Ophthalmology 48
    • 7.5 Reconstructive & Plastic Surgery 48
    • 7.6 Oncology 49

    8 Global Microsurgery Market, By Equipment 50

    • 8.1 Introduction 51
    • 8.2 Microsurgical Instruments 52
    • 8.3 Microscope 52
    • 8.4 Suture Materials 53

    9 Global Microsurgery Market, By End User 54

    • 9.1 Introduction 55
    • 9.2 Hospitals & Clinics 56
    • 9.3 Ambulatory Surgical Centers 56
    • 9.4 Research Organizations 56

    10 Global Microsurgery Market, By Region 57

    • 10.1 Introduction 58
    • 10.2 Americas 59
      • 10.2.1 North America 62
        • 10.2.1.1 U.S 65
        • 10.2.1.2 Canada 68
      • 10.2.2 South America 70
    • 10.3 Europe 72
      • 10.3.1 Western Europe 75
        • 10.3.1.1 Germany 78
        • 10.3.1.2 France 80
        • 10.3.1.3 U.K 82
        • 10.3.1.4 Italy 85
        • 10.3.1.5 Spain 87
        • 10.3.1.6 Rest of Western Europe 89
      • 10.3.2 Eastern Europe 92
    • 10.4 Asia Pacific 94
      • 10.4.1 Japan 97
      • 10.4.2 China 100
      • 10.4.3 India 102
      • 10.4.4 Republic of Korea 104
      • 10.4.5 Rest of Asia-Pacific 107
    • 10.5 Middle East & Africa 109
      • 10.5.1 Middle East 112
      • 10.5.2 Africa 114

    11 Competitive Landscape 117

    • 11.1.1 Introduction 118

    12 Company Profile 119

    • 12.1 S&T AG 120
      • 12.1.1 Company Overview 120
      • 12.1.2 Financial Overview 120
      • 12.1.3 Products Offering 120
      • 12.1.4 Key Developments 121
      • 12.1.5 SWOT Analysis 122
      • 12.1.6 Key Strategy 122
    • 12.2 Aesculap, Inc., a B. Braun company 123
      • 12.2.1 Company Overview 123
      • 12.2.2 Financial Overview 123
      • 12.2.3 Products Offering 124
      • 12.2.4 Key Developments 124
      • 12.2.5 SWOT Analysis 124
      • 12.2.6 Key Strategy 124
    • 12.3 Synovis Micro Companies Alliance, Inc. 125
      • 12.3.1 Company Overview 125
      • 12.3.2 Financial Overview 125
      • 12.3.3 Products Offering 126
      • 12.3.4 Key Developments 126
      • 12.3.5 SWOT Analysis 126
      • 12.3.6 Key Strategy 126
    • 12.4 Ethicon Inc. 127
      • 12.4.1 Company Overview 127
      • 12.4.2 Financial Overview 127
      • 12.4.3 Products Offering 128
      • 12.4.4 Key Developments 128
      • 12.4.5 SWOT Analysis 129
      • 12.4.6 Key Strategy 129
    • 12.5 Stryker Corporation 130
      • 12.5.1 Company Overview 130
      • 12.5.2 Financial Overview 130
      • 12.5.3 Products Offering 131
      • 12.5.4 Key Developments 131
      • 12.5.5 SWOT Analysis 132
      • 12.5.6 Key Strategy 132
    • 12.6 Smith & Nephew 133
      • 12.6.1 Company Overview 133
      • 12.6.2 Financial Overview 133
      • 12.6.3 Products Offering 134
      • 12.6.4 Key Developments 134
      • 12.6.5 SWOT Analysis 135
      • 12.6.6 Key Strategy 135
    • 12.7 Alcon (Novartis) 136
      • 12.7.1 Company Overview 136
      • 12.7.2 Financial Overview 136
      • 12.7.3 Products Offering 137
      • 12.7.4 Key Developments 137
      • 12.7.5 SWOT Analysis 137
      • 12.7.6 Key Strategy 138
    • 12.8 Zimmer Biomet Holdings 139
      • 12.8.1 Company Overview 139
      • 12.8.2 Financial Overview 139
      • 12.8.3 Products Offering 140
      • 12.8.4 Key Developments 140
      • 12.8.5 SWOT Analysis 141
      • 12.8.6 Key Strategy 141
    • 12.9 Medtronic Plc 142
      • 12.9.1 Company Overview 142
      • 12.9.2 Financial Overview 142
      • 12.9.3 Products Offering 143
      • 12.9.4 Key Developments 143
      • 12.9.5 SWOT Analysis 143
      • 12.9.6 Key Strategy 143
    • 12.10 Carl Zeiss Meditec AG 144
      • 12.10.1 Company Overview 144
      • 12.10.2 Financial Overview 144
      • 12.10.3 Products Offering 145
      • 12.10.4 Key Developments 145
      • 12.10.5 SWOT Analysis 145
      • 12.10.6 Key Strategy 145
    • 12.11 Peter Lazic GmbH 146
      • 12.11.1 Company Overview 146
      • 12.11.2 Financial Overview 146
      • 12.11.3 Products Offering 146
      • 12.11.4 Key Developments 146
      • 12.11.5 SWOT Analysis 147
      • 12.11.6 Key Strategy 147
    • 12.12 Microsurgery Instruments, Inc. 148
      • 12.12.1 Company Overview 148
      • 12.12.2 Financial Overview 148
      • 12.12.3 Products Offering 148
      • 12.12.4 Key Developments 148
      • 12.12.5 SWOT Analysis 149
      • 12.12.6 Key Strategy 149
    • 12.13 Tisurg medical instruments Co., Ltd. 150
      • 12.13.1 Company Overview 150
      • 12.13.2 Financial Overview 150
      • 12.13.3 Products Offering 150
      • 12.13.4 Key Developments 150
      • 12.13.5 SWOT Analysis 150
      • 12.13.6 Key Strategy 150
    • 12.14 Microline Surgical 151
      • 12.14.1 Company Overview 151
      • 12.14.2 Financial Overview 151
      • 12.14.3 Products Offering 152
      • 12.14.4 Key Developments 153
      • 12.14.5 SWOT Analysis 154
      • 12.14.6 Key Strategy 154
    • 12.15 AROSurgical Instruments 155
      • 12.15.1 Company Overview 155
      • 12.15.2 Financial Overview 155
      • 12.15.3 Products Offering 155
      • 12.15.4 Key Developments 156
      • 12.15.5 SWOT Analysis 156
      • 12.15.6 Key Strategy 156
    • 12.16 Halma plc 157
      • 12.16.1 Company Overview 157
      • 12.16.2 Financial Overview 157
      • 12.16.3 Products Offering 158
      • 12.16.4 Key Developments 158
      • 12.16.5 SWOT Analysis 158
      • 12.16.6 Key Strategy 158

    13 Appendix 159

    • 13.1 Discussion Blue Print 160

    Report You Might be Interested